Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Homoharringtonine Combined With ADT in Neoadjuvant Prostate Cancer
NCT07163910Phase 2Recruiting
- Start
- Apr 2025
- Primary completion
- Sep 2027
- Modality
- Nucleic Acid-Directed Small Molecules, Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of homoharringtonine in prostate cancer (PCa). Started Apr 2025; status: recruiting.
02
Drugs
homoharringtonine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT07163910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07163910.